Jorge Arbelbide
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Iron Metabolism and Disorders
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 22
- Acute Myeloid Leukemia Research 14
- Multiple Myeloma Research and Treatments 6
- Chronic Myeloid Leukemia Treatments 4
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 4
- Co-authors
- Dorotea Fantl (9 shared papers)Irma Slavutsky (5 shared papers)Fernando Brites (4 shared papers)Patricia Sorroche (5 shared papers)Tomás Meroño (4 shared papers)Laura Boero (4 shared papers)Carlos G. Musso (1 shared paper)Leonardo Gómez Rosso (2 shared papers)
In The Last Decade
Jorge Arbelbide
31 papers receiving 254 citations
Peers
Comparison fields: 5 of 50
- Hematology 122
- Genetics 47
- Nephrology 14
- Pharmacology 15
- Clinical Biochemistry 9
Countries citing papers authored by Jorge Arbelbide
This map shows the geographic impact of Jorge Arbelbide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Arbelbide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Arbelbide more than expected).
Fields of papers citing papers by Jorge Arbelbide
This network shows the impact of papers produced by Jorge Arbelbide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Arbelbide. The network helps show where Jorge Arbelbide may publish in the future.
Co-authors
The 25 scholars most cited alongside Jorge Arbelbide, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 34 | |
| 2 | 2010 | 31 | |
| 3 | 2016 | 24 | |
| 4 | 2017 | 24 | |
| 5 | 2011 | 22 | |
| 6 | 2013 | 20 | |
| 7 | 2012 | 17 | |
| 8 | 2010 | 16 | |
| 9 | 2009 | 11 | |
| 10 | 2019 | 10 | |
| 11 | 2020 | 8 | |
| 12 | 2020 | 7 | |
| 13 | 2017 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2011 | 2 | |
| 16 | 2017 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2015 | 2 | |
| 19 | 2019 | 2 | |
| 20 | [Prognostic value of the expression of MDR-1 in acute myeloid leukemia]. | 2003 | 2 |
About Jorge Arbelbide
Jorge Arbelbide is a scholar working on Hematology, Molecular Biology, Genetics, Physiology and Nephrology, having authored 32 papers that have together received 256 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Multiple Myeloma Research and Treatments (6 papers), Chronic Myeloid Leukemia Treatments (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Paraoxonase enzyme and polymorphisms (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Hematological disorders and diagnostics (3 papers) and Telomeres, Telomerase, and Senescence (3 papers). The work is most often cited by research in Hematology (122 citations), Genetics (47 citations), Nephrology (14 citations), Pharmacology (15 citations) and Clinical Biochemistry (9 citations). Jorge Arbelbide has collaborated with scholars based in Argentina, Spain and Brazil. Frequent co-authors include Dorotea Fantl, Irma Slavutsky, Fernando Brites, Patricia Sorroche, Tomás Meroño, Laura Boero, Carlos G. Musso, Leonardo Gómez Rosso, Claudia Corrado and Hernán Garcı́a Rivello. Their work appears in journals such as Annals of Hematology, Blood, Amyloid, Bone Marrow Transplantation and Blood Cells Molecules and Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.